Given their essential function in aerobic metabolism, mitochondria are intuitively of interest in regard to the pathophysiology of diabetes. Qualitative, quantitative, and functional perturbations in mitochondria have been identified and affect the cause and complications of diabetes. Moreover, as a consequence of fuel oxidation, mitochondria generate considerable reactive oxygen species (ROS). Evidence is accumulating that these radicals per se are important in the pathophysiology of diabetes and its complications. In this review, we first present basic concepts underlying mitochondrial physiology. We then address mitochondrial function and ROS as related to diabetes. We consider different forms of diabetes and address both insulin secretion and insulin sensitivity. We also address the role of mitochondrial uncoupling and coenzyme Q. Finally, we address the potential for targeting mitochondria in the therapy of diabetes. Antioxid. Redox Signal. 12, 537–577.
Abdul-GhaniMA, DeFronzoRA. Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr Diabetis Rep, 8:173–178. 2008.
2.
AbergF, AppelkvistEL, DallnerG, ErnsterL. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys, 295:230–234. 1992.
3.
AbrahamNG, KappasA. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev, 60:79–127. 2008.
Abu-ElheigaL, OhW, KordariP, WakilSJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci U S A, 100:10207–10212. 2003.
6.
Adam-ViziV. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal, 7:1140–1149. 2005.
7.
AdlamVJ, HarrisonJC, PorteousCM, JamesAM, SmithRA, MurphyMP, SammutIA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J, 19:1088–1095. 2005.
8.
AffourtitC, BrMD. On the role of uncoupling protein-2 in pancreatic beta cells. Biochim Biophys Acta, 1777:973–979. 2008.
9.
AffourtitC, BrMD. Stronger control of ATP/ADP by proton leak in pancreatic beta-cells than skeletal muscle mitochondria. Biochem J, 393:151–159. 2006.
10.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 32,suppl 1:S62–S67. 2009.
11.
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care, 32,suppl 1:S13–S61. 2009.
AndersenCB, HenriksenJE, Hother-NielsenO, VaagA, MortensenSA, Beck-NielsenH. The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin dependent diabetes mellitus. Mol Aspects Med, 18,suppl:S307–S309. 1997.
14.
AndersonEJ, LustigME, BoyleKE, WoodliefTL, KaneDA, LinCT, PriceJW3rd, KangL, RabinovitchPS, SzetoHH, HoumardJA, CortrightRN, WassermanDH, NeuferPD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest, 2009[Epub ahead of print].
15.
AranyZ, HeH, LinJ, HoyerK, HandschinC, TokaO, AhmadF, MatsuiT, ChinS, WuPH, RybkinII, SheltonJM, ManieriM, CintiS, SchoenFJ, Bassel-DubyR, RosenzweigA, IngwallJS, SpiegelmanBM. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab, 1:259–271. 2005.
16.
ArechagaI, LedesmaA, RialE. The mitochondrial uncoupling protein UCP1: a gated pore. IUBMB Life, 52:165–173. 2001.
17.
ArgyropoulosG, BrownAM, WilliSM, ZhuJ, HeY, ReitmanM, GevaoSM, SpruillI, GarveyWT. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest, 102:1345–1351. 1998.
18.
AsabaK, TojoA, OnozatoML, GotoA, FujitaT. Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol, 49:13–19. 2007.
BastarI, SeckinS, UysalM, Aykac-TokerG. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol, 102:265–272. 1998.
22.
BaurJA, PearsonKJ, PriceNL, JamiesonHA, LerinC, KalraA, PrabhuVV, AllardJS, Lopez-LluchG, LewisK, PistellPJ, PoosalaS, BeckerKG, BossO, GwinnD, WangM, RamaswamyS, FishbeinKW, SpencerRG, LakattaEG, Le CouteurD, ShawRJ, NavasP, PuigserverP, IngramDK, de CaboR, SinclairDA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444:337–342. 2006.
23.
BeckmanJA, GoldfineAB, GordonMB, GarrettLA, KeaneyJFJr, CreagerMA. Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol, 285:H2392–H2398. 2003.
24.
BeckmanKB, AmesBN. The free radical theory of aging matures. Physiol Rev, 78:547–581. 1998.
25.
BedogniB, PaniG, ColavittiR, RiccioA, BorrelloS, MurphyM, SmithR, EboliML, GaleottiT. Redox regulation of cAMP-responsive element-binding protein and induction of manganous superoxide dismutase in nerve growth factor-dependent cell survival. J Biol Chem, 278:16510–16519. 2003.
26.
BefroyDE, PetersenKF, DufourS, MasonGF, de GraafRA, RothmanDL, ShulmanGI. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes, 56:1376–1381. 2007.
27.
BentonCR, NickersonJG, LallyJ, HanXX, HollowayGP, GlatzJF, LuikenJJ, GrahamTE, HeikkilaJJ, BonenA. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem, 283:4228–4240. 2008.
28.
BergeronR, RenJM, CadmanKS, MooreIK, PerretP, PypaertM, YoungLH, SemenkovichCF, ShulmanGI. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab, 281:E1340–E1346. 2001.
29.
BerlieHD, KalusJS, JaberLA. Thiazolidinediones and the risk of edema: a meta-analysis. Diabetes Res Clin Pract, 76:279–289. 2007.
30.
BogackaI, XieH, BrayGA, SmithSR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes, 54:1392–1399. 2005.
31.
BossO, HagenT, LowellBB. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes, 49:143–156. 2000.
32.
BossO, SamecS, Paoloni-GiacobinoA, RossierC, DullooA, SeydouxJ, MuzzinP, GiacobinoJP. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett, 408:39–42. 1997.
BoudinaS, SenaS, TheobaldH, ShengX, WrightJJ, HuXX, AzizS, JohnsonJI, BuggerH, ZahaVG, AbelED. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes, 56:2457–2466. 2007.
35.
BoushelR, GnaigerE, SchjerlingP, SkovbroM, KraunsoeR, DelaF. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia, 50:790–796. 2007.
36.
BouzakriK, AustinR, RuneA, LassmanME, Garcia-RovesPM, BergerJP, KrookA, ChibalinAV, ZhangBB, ZierathJR. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle. Diabetes, 57:1508–1516. 2008.
37.
BoverisA, OshinoN, ChanceB. The cellular production of hydrogen peroxide. Biochem J, 128:617–630. 1972.
38.
BoverisAA, Cattaneo de PeraltaR, StoppaniAO, FogliaVG. Phosphorylation, oxidation, and ubiquinone content in diabetic mitochondria. Proc Soc Exp Biol Med, 132:171–174. 1969.
39.
BrandMD, BrindleKM, BuckinghamJA, HarperJA, RolfeDF, StuartJA. The significance and mechanism of mitochondrial proton conductance. Int J Obes Rel Metab Dis, J Int Assoc Study Obes, 23:S4–S11. 1999.
BuggerH, BoudinaS, HuXX, TuineiJ, ZahaVG, TheobaldHA, YunUJ, McQueenAP, WaymentB, LitwinSE, AbelED. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes, 57:2924–2932. 2008.
43.
BusikJV, MohrS, GrantMB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes, 57:1952–1965. 2008.
44.
CadenasS, BuckinghamJA, SamecS, SeydouxJ, DinN, DullooAG, BrMD. UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged. FEBS Lett, 462:257–260. 1999.
45.
CadenasS, EchtayKS, HarperJA, JekabsonsMB, BuckinghamJA, GrauE, AbuinA, ChapmanH, ClaphamJC, BrMD. The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J Biol Chem, 277:2773–2778. 2002.
46.
CameronNE, CotterMA. Effects of an extracellular metal chelator on neurovascular function in diabetic rats. Diabetologia, 44:621–628. 2001.
47.
CameronNE, CotterMA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes, 46,suppl 2:S31–S37. 1997.
48.
CameronNE, CotterMA. Neurovascular dysfunction in diabetic rats: potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest, 96:1159–1163. 1995.
49.
CameronNE, CotterMA, MaxfieldEK. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia, 36:299–304. 1993.
50.
CameronNE, JackAM, CotterMA. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med, 31:125–135. 2001.
51.
CameronNE, TuckZ, McCabeL, CotterMA. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia, 44:1161–1169. 2001.
52.
CantoC, AuwerxJ. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol, 20:98–105. 2009.
53.
CerielloA. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care, 26:1589–1596. 2003.
54.
CesterN, RabiniRA, SalvoliniE, StaffolaniR, CuratolaA, PugnaloniA, BrunelliMA, BiaginiG, MazzantiL. Activation of endothelial cells during insulin-dependent diabetes mellitus: a biochemical and morphological study. Eur J Clin Invest, 26:569–573. 1996.
55.
ChanCB, MacDonaldPE, SalehMC, JohnsDC, MarbanE, WheelerMB. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes, 48:1482–1486. 1999.
ChanceB, WilliamsGR. Respiratory enzymes in oxidative phosphorylation, III: the steady state. J Biol Chem, 217:409–427. 1955.
59.
ChaoTT, IanuzzoCD, ArmstrongRB, AlbrightJT, AnapolleSE. Ultrastructural alterations in skeletal muscle fibers of streptozotocin-diabetic rats. Cell Tissue Res, 168:239–246. 1976.
60.
ChoiSL, KimSJ, LeeKT, KimJ, MuJ, BirnbaumMJ, Soo KimS, HaJ. The regulation of AMP-activated protein kinase by H(2)O(2)Biochem Biophys Res Commun, 287:92–97. 2001.
61.
ChooHJ, KimJH, KwonOB, LeeCS, MunJY, HanSS, YoonYS, YoonG, ChoiKM, KoYG. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia, 49:784–791. 2006.
62.
ChungWK, LukeA, CooperRS, RotiniC, Vidal-PuigA, RosenbaumM, ChuaM, SolanesG, ZhengM, ZhaoL, LeDucC, EisbergA, ChuF, MurphyE, SchreierM, AronneL, CaprioS, KahleB, GordonD, LealSM, GoldsmithR, AndreuAL, BrunoC, DiMauroS, HeoM, LoweWL, LowellBB, AllisonDB, LeibelRL. Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes, 48:1890–1895. 1999.
ClineGW, Vidal-PuigAJ, DufourS, CadmanKS, LowellBB, ShulmanGI. In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem, 276:20240–20244. 2001.
65.
CollinsAR, RaslovaK, SomorovskaM, PetrovskaH, OndrusovaA, VohnoutB, FabryR, DusinskaM. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med, 25:373–377. 1998.
66.
ConstantinescuA, MaguireJJ, PackerL. Interactions between ubiquinones and vitamins in membranes and cells. Mol Aspects Med, 15,suppl:s57–s65. 1994.
67.
CoppeyLJ, GellettJS, DavidsonEP, DunlapJA, LundDD, SalveminiD, YorekMA. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br J Pharmacol, 134:21–29. 2001.
68.
CoppeyLJ, GellettJS, DavidsonEP, DunlapJA, LundDD, YorekMA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50:1927–1937. 2001.
69.
CoppeyLJ, GellettJS, DavidsonEP, DunlapJA, YorekMA. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Int J Exp Diabetes Res, 3:21–36. 2002.
70.
CoppeyLJ, GellettJS, DavidsonEP, YorekMA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res, 37:33–40. 2003.
71.
CotgreaveIA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol, 38:205–227. 1997.
72.
CoughlanMT, Thallas-BonkeV, PeteJ, LongDM, GasserA, TongDC, ArnsteinM, ThorpeSR, CooperME, ForbesJM. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Endocrinology, 148:886–895. 2007.
73.
CouplanE, del Mar Gonzalez-BarrosoM, Alves-GuerraMC, RicquierD, GoubernM, BouillaudF. No evidence for a basal, retinoic, or superoxide-induced uncoupling activity of the uncoupling protein 2 present in spleen or lung mitochondria. J Biol Chem, 277:26268–26275. 2002.
74.
CravenPA, StuderRK, NegreteH, DeRubertisFR. Protein kinase C in diabetic nephropathy. J Diabetes Complications, 9:241–245. 1995.
CuiY, XuX, BiH, ZhuQ, WuJ, XiaX, QiushiR, HoPC. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp Eye Res, 83:807–816. 2006.
77.
CuttingWC, MehrtensHG, TainterML. Actions and uses of dinitrophenol. JAMA, 101:193–195. 1933.
78.
CypessAM, LehmanS, WilliamsG, TalI, RodmanD, GoldfineAB, KuoFC, PalmerEL, TsengYH, DoriaA, KolodnyGM, KahnCR. Identification and importance of brown adipose tissue in adult humans. N Engl J Med, 360:1509–1517. 2009.
79.
de CavanaghEM, FerderL, ToblliJE, PiotrkowskiB, StellaI, FragaCG, InserraF. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes. Am J Physiol Heart Circ Physiol, 294:H456–H465. 2008.
80.
De VrieseAS, VerbeurenTJ, Van de VoordeJ, LameireNH, VanhouttePM. Endothelial dysfunction in diabetes. Br J Pharmacol, 130:963–974. 2000.
81.
DhanasekaranA, KotamrajuS, KalivendiSV, MatsunagaT, ShangT, KeszlerA, JosephJ, KalyanaramanB. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem, 279:37575–37587. 2004.
82.
Di NoiaMA, Van DriescheS, PalmieriF, YangLM, QuanS, GoodmanAI, AbrahamNG. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem, 281:15687–15693. 2006.
83.
DincerY, TelciA, KayaliR, YilmazIA, CakatayU, AkcayT. Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin Exp Pharmacol Physiol, 29:281–284. 2002.
84.
DoughanAK, DikalovSI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal, 9:1825–1836. 2007.
85.
DroseS, BrandtU. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem, 283:21649–21654. 2008.
86.
DuXL, EdelsteinD, RossettiL, FantusIG, GoldbergH, ZiyadehF, WuJ, BrownleeM. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A, 97:12222–12226. 2000.
87.
DuY, MillerCM, KernTS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med, 35:1491–1499. 2003.
88.
DulakJ, DeshaneJ, JozkowiczA, AgarwalA. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation, 117:231–241. 2008.
89.
DuncanJG, FongJL, MedeirosDM, FinckBN, KellyDP. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation, 115:909–917. 2007.
90.
DuttonPL, MoserCC, SledVD, DaldalF, OhnishiT. A reductant-induced oxidation mechanism for complex I. Biochim Biophys Acta, 1364:245–257. 1998.
91.
EchtayKS, EstevesTC, PakayJL, JekabsonsMB, LambertAJ, Portero-OtinM, PamplonaR, Vidal-PuigAJ, WangS, RoebuckSJ, BrMD. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J, 22:4103–4110. 2003.
92.
EchtayKS, MurphyMP, SmithRA, TalbotDA, BrMD. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side: studies using targeted antioxidants. J Biol Chem, 277:47129–47135. 2002.
EchtayKS, WinklerE, FrischmuthK, KlingenbergM. Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone)Proc Natl Acad Sci U S A, 98:1416–1421. 2001.
95.
EconomidesPA, KhaodhiarL, CaselliA, CaballeroAE, KeenanH, BursellSE, KingGL, JohnstoneMT, HortonES, VevesA. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes, 54:204–211. 2005.
96.
EmreY, HurtaudC, KaracaM, NubelT, ZavalaF, RicquierD. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proc Natl Acad Sci U S A, 104:19085–19090. 2007.
97.
ErnsterL, ForsmarkP, NordenbrK. The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Biofactors, 3:241–248. 1992.
98.
ErusalimskyJD, MoncadaS. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol, 27:2524–2531. 2007.
FinkBD, O'MalleyY, DakeBL, RossNC, PrisinzanoTE, SivitzWI. Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS ONE, 4:e4250. 2009.
105.
FinkBD, ReszkaKJ, HerleinJA, MathahsMM, SivitzWI. Respiratory uncoupling by UCP1 and UCP2 and superoxide generation in endothelial cell mitochondria. Am J Physiol, Endocrinol Metab, 288:E71–E79. 2005.
106.
FleuryC, NeverovaM, CollinsS, RaimbaultS, ChampignyO, Levi-MeyrueisC, BouillaudF, SeldinMF, SurwitRS, RicquierD, WardenCH. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet, 15:269–272. 1997.
107.
FridovichI. Superoxide anion radical (O2−·), superoxide dismutases, and related matters. J Biol Chem, 272:18515–18517. 1997.
108.
FriederichM, FaschingA, HansellP, NordquistL, PalmF. Diabetes-induced up-regulation of uncoupling protein-2 results in increased mitochondrial uncoupling in kidney proximal tubular cells. Biochim Biophys Acta, 1777:935–940. 2008.
109.
FujiiN, JessenN, GoodyearLJ. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab, 291:E867–E877. 2006.
110.
GardnerPR. Superoxide-driven aconitase FE-S center cycling. Biosci Rep, 17:33–42. 1997.
111.
Gat-YablonskiG, ShalitinS, PhillipM. Maturity onset diabetes of the young: review. Pediatr Endocrinol Rev, 3,suppl 3:514–520. 2006.
112.
GautierJF, WilsonC, WeyerC, MottD, KnowlerWC, CavaghanM, PolonskyKS, BogardusC, PratleyRE. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes, 50:1828–1833. 2001.
113.
GhirlandaG, OradeiA, MantoA, LippaS, UccioliL, CaputoS, GrecoAV, LittarruGP. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol, 33:226–229. 1993.
GotoY, NonakaI, HoraiS. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature, 348:651–653. 1990.
116.
GotoY, OliveiraPJ, RoloAP, SeicaR, PalmeiraCM, SantosMS, MorenoAJ. Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate. Biosci Rep, 21:45–53. 2001.
117.
GreenK, BrandMD, MurphyMP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes, 53:S110–S118. 2004.
118.
GrivennikovaVG, VinogradovAD. Generation of superoxide by the mitochondrial complex I. Biochim Biophys Acta, 1757:553–561. 2006.
119.
GrossMD, HarrisS, BeyerRE. The effect of streptozotocin-induced diabetes on oxidative phosphorylation and related reactions in skeletal muscle mitochondria. Horm Metab Res, 4:1–7. 1972.
120.
GroupUS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352:837–853. 1998.
121.
GuarenteL. Mitochondria: a nexus for aging, calorie restriction, and sirtuins?Cell, 132:171–176. 2008.
122.
GulliG, FerranniniE, SternM, HaffnerS, DeFronzoRA. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes, 41:1575–1586. 1992.
GunterTE, GunterKK. Uptake of calcium by mitochondria: transport and possible function. IUBMB Life, 52:197–204. 2001.
125.
GunterTE, YuleDI, GunterKK, EliseevRA, SalterJD. Calcium and mitochondria. FEBS Lett, 567:96–102. 2004.
126.
HaasRH. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease. Mitochondrion, 7,suppl:S136–S145. 2007.
127.
HallJC, SordahlLA, StefkoPL. The effect of insulin on oxidative phosphorylation in normal and diabetic mitochondria. J Biol Chem, 235:1536–1539. 1960.
128.
HanDWE, CadenasE. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J, 353:411–416. 2001.
HaydenMR, SowersJR. Isletopathy in type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxid Redox Signal, 9:891–910. 2007.
131.
HeJ, WatkinsS, KelleyDE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes, 50:817–823. 2001.
132.
HenriksenEJ. Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol, 93:788–796. 2002.
133.
HenriksenJE, AndersenCB, Hother-NielsenO, VaagA, MortensenSA, Beck-NielsenH. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with type 1 diabetes mellitus. Diabetes Med, 16:312–318. 1999.
134.
HerleinJA, FinkBD, O'MalleyY, SivitzWI. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology, 150:46–55. 2009.
135.
HesselinkMK, GreenhaffPL, Constantin-TeodosiuD, HultmanE, SarisWH, NieuwlaatR, SchaartG, KornipsE, SchrauwenP. Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. J Clin Invest, 111:479–486. 2003.
136.
HesselinkMKC, MensinkM, SchrauwenP. Human uncoupling protein-3 and obesity: an update. Obesity Res, 11:1429–1443. 2003.
137.
HirosumiJ, TuncmanG, ChangL, GorgunCZ, UysalKT, MaedaK, KarinM, HotamisligilGS. A central role for JNK in obesity and insulin resistance. Nature, 420:333–336. 2002.
138.
HoeldtkeRD, BrynerKD, McNeillDR, WarehimeSS, Van DykeK, HobbsG. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab, 88:1624–1628. 2003.
139.
HojlundK, WrzesinskiK, LarsenPM, FeySJ, RoepstorffP, HandbergA, DelaF, VintenJ, McCormackJG, ReynetC, Beck-NielsenH. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem, 278:10436–10442. 2003.
140.
HongY, FinkBD, DillonJS, SivitzWI. Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells. Endocrinology, 142:249–256. 2001.
141.
HorieT, OnoK, NagaoK, NishiH, KinoshitaM, KawamuraT, WadaH, ShimatsuA, KitaT, HasegawaK. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol, 215:733–742. 2008.
142.
HoustisN, RosenED, LanderES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440:944–948. 2006.
HuieRE, PadmajaS. The reaction of no with superoxide. Free Radic Res Commun, 18:195–199. 1993.
145.
InksterME, CotterMA, CameronNE. Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats. Free Radic Res, 36:1091–1099. 2002.
JamesAM, SmithRA, MurphyMP. Antioxidant and prooxidant properties of mitochondrial coenzyme Q. Arch Biochem Biophys, 423:47–56. 2004.
148.
JauslinML, MeierT, SmithRA, MurphyMP. Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J, 17:1972–1974. 2003.
149.
JekabsonsMB, NichollsDG. In situ respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate. J Biol Chem, 279:32989–33000. 2004.
150.
JoSH, KooBK, ParkJS, KangHJ, KimYJ, KimHL, ChaeIH, ChoiDJ, SohnDW, OhBH, ParkYB, ChoiYS, KimHS. N-acetylcysteine versus ascorbic acid for preventing contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study: a prospective randomized controlled trial. Am Heart J, 157:576–583. 2009.
151.
Johnson-CadwellLI, JekabsonsMB, WangA, PolsterBM, NichollsDG. “Mild uncoupling” does not decrease mitochondrial superoxide levels in cultured cerebellar granule neurons but decreases spare respiratory capacity and increases toxicity to glutamate and oxidative stress. J Neurochem, 101:1619–1631. 2007.
152.
JosephJW, KoshkinV, SalehMC, SivitzWI, ZhangCY, LowellBB, ChanCB, WheelerMB. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem, 279:51049–51056. 2004.
153.
JosephJW, KoshkinV, ZhangCY, WangJ, LowellBB, ChanCB, WheelerMB. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes, 51:3211–3219. 2002.
154.
KamoN, MuratsuguM, HongohR, KobatakeY. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol, 49:105–121. 1979.
155.
KanauchiM, NishiokaH, HashimotoT. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron, 91:327–329. 2002.
156.
KanwarM, ChanPS, KernTS, KowluruRA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci, 48:3805–3811. 2007.
157.
KarakelidesH, AsmannYW, BigelowML, ShortKR, DhatariyaK, Coenen-SchimkeJ, KahlJ, MukhopadhyayD, NairKS. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes, 56:2683–2689. 2007.
158.
KatakamPV, JordanJE, SnipesJA, TulbertCD, MillerAW, BusijaDW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol, 292:R920–R926. 2007.
159.
KatyareSS, SatavJG. Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria: a comparative study of early and late effects. Diabetes Obes Metab, 7:555–562. 2005.
160.
KeeganA, CotterMA, CameronNE. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia, 42:343–350. 1999.
161.
KelleyDE, HeJ, MenshikovaEV, RitovVB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 51:2944–2950. 2002.
162.
KelsoGF, PorteousCM, CoulterCV, HughesG, PorteousWK, LedgerwoodEC, SmithRA, MurphyMP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem, 276:4588–4596. 2001.
163.
KhailovaLS, PrikhodkoEA, DedukhovaVI, MokhovaEN, PopovVN, SkulachevVP. Participation of ATP/ADP antiporter in oleate- and oleate hydroperoxide-induced uncoupling suppressed by GDP and carboxyatractylate. Biochim Biophys Acta, 1757:1324–1329. 2006.
164.
KimJA, WeiY, SowersJR. Role of mitochondrial dysfunction in insulin resistance. Circ Res, 102:401–414. 2008.
165.
KiritoshiS, NishikawaT, SonodaK, KukidomeD, SenokuchiT, MatsuoT, MatsumuraT, TokunagaH, BrownleeM, ArakiE. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes, 52:2570–2577. 2003.
166.
KnowlerWC, Barrett-ConnorE, FowlerSE, HammanRF, LachinJM, WalkerEA, NathanDM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346:393–403. 2002.
167.
KorshunovSS, SkulachevVP, StarkovAA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett, 416:15–18. 1997.
KowluruRA, AbbasSN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci, 44:5327–5334. 2003.
173.
KowluruRA, KowluruV, XiongY, HoYS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med, 41:1191–1196. 2006.
174.
KowluruRA, OdenbachS. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes, 53:3233–3238. 2004.
175.
Krause MdaS, de BittencourtPIJr. Type 1 diabetes: can exercise impair the autoimmune event: the L-arginine/glutamine coupling hypothesis. Cell Biochem Funct, 26:406–433. 2008.
KrebsM, RodenM. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab, 7:621–632. 2005.
178.
KroemerG, ZamzamiN, SusinSA. Mitochondrial control of apoptosis. Immunol Today, 18:44–51. 1997.
179.
KubischHM, WangJ, BrayTM, PhillipsJP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes, 46:1563–1566. 1997.
180.
KucharskaJ, BraunovaZ, UlicnaO, ZlatosL, GvozdjakovaA. Deficit of coenzyme Q in heart and liver mitochondria of rats with streptozotocin-induced diabetes. Physiol Res, 49:411–418. 2000.
181.
KukidomeD, NishikawaT, SonodaK, ImotoK, FujisawaK, YanoM, MotoshimaH, TaguchiT, MatsumuraT, ArakiE. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes, 55:120–127. 2006.
182.
KunitomoM, YamaguchiY, KagotaS, OtsuboK. Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci, 107:128–137. 2008.
183.
LaczaZ, PankotaiE, BusijaDW. Mitochondrial nitric oxide synthase: current concepts and controversies. Front Biosci, 14:4436–4443. 2009.
184.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, ElliottP, GenyB, LaaksoM, PuigserverP, AuwerxJ. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127:1109–1122. 2006.
185.
LambertAJ, BrMD. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I)J Biol Chem, 279:39414–39420. 2004.
186.
LashinO, RomaniA. Hyperglycemia does not alter state 3 respiration in cardiac mitochondria from type-I diabetic rats. Mol Cell Biochem, 267:31–37. 2004.
187.
LashinOM, SzwedaPA, SzwedaLI, RomaniAM. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic Biol Med, 40:886–896. 2006.
188.
LaurindoFR, FernandesDC, SantosCX. Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. Methods Enzymol, 441:237–260. 2008.
189.
LeeCK, KloppRG, WeindruchR, ProllaTA. Gene expression profile of aging and its retardation by caloric restriction. Science, 285:1390–1393. 1999.
190.
LenzenS, DrinkgernJ, TiedgeM. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med, 20:463–466. 1996.
LiM, KimDH, TsenovoyPL, PetersonSJ, RezzaniR, RodellaLF, AronowWS, IkeharaS, AbrahamNG. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes, 57:1526–1535. 2008.
193.
LiM, PetersonS, HusneyD, InabaM, GuoK, TeradaE, MoritaT, PatilK, KappasA, IkeharaS, AbrahamNG. Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal, 9:855–863. 2007.
194.
LiN, FrigerioF, MaechlerP. The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem Soc Trans, 36:930–934. 2008.
195.
LiX, MayJM. Catalase-dependent measurement of H2O2 in intact mitochondria. Mitochondrion, 1:447–453. 2002.
196.
LiZ, OkamotoK, HayashiY, ShengM. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell, 119:873–887. 2004.
197.
LiangP, HughesV, FukagawaNK. Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes, 46:920–923. 1997.
LinJ, WuPH, TarrPT, LindenbergKS, St-PierreJ, ZhangCY, MoothaVK, JagerS, ViannaCR, ReznickRM, CuiL, ManieriM, DonovanMX, WuZ, CooperMP, FanMC, RohasLM, ZavackiAM, CintiS, ShulmanGI, LowellBB, KraincD, SpiegelmanBM. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119:121–135. 2004.
200.
LindroosMM, MajamaaK, TuraA, MariA, KalliokoskiKK, TaittonenMT, IozzoP, NuutilaP. The m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive {beta}-cell dysfunction. Diabetes, 58:543–549. 2008.
201.
LonnE, BoschJ, YusufS, SheridanP, PogueJ, ArnoldJM, RossC, ArnoldA, SleightP, ProbstfieldJ, DagenaisGR. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 293:1338–1347. 2005.
202.
LonnE, YusufS, DzavikV, DorisC, YiQ, SmithS, Moore-CoxA, BoschJ, RileyW, TeoK. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)Circulation, 103:919–925. 2001.
203.
Lopez-LluchG, HuntN, JonesB, ZhuM, JamiesonH, HilmerS, CascajoMV, AllardJ, IngramDK, NavasP, de CaboR. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci U S A, 103:1768–1773. 2006.
204.
LowellBB, ShulmanGI. Mitochondrial dysfunction and type 2 diabetes. Science, 307:384–387. 2005.
MaassenJA, HartLM, JanssenGM, ReilingE, RomijnJA, LemkesHH. Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochem Soc Trans, 34:819–823. 2006.
MarinariUM, MonacelliR, CottalassoD, NovelliA. Effects of alloxan diabetes and insulin on morphology and certain functional activities of mitochondria of the rat liver and heart. Acta Diabetol Lat, 11:296–314. 1974.
210.
MarraG, CotroneoP, PitoccoD, MantoA, Di LeoMA, RuotoloV, CaputoS, GiardinaB, GhirlandaG, SantiniSA. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care, 25:370–375. 2002.
211.
MatschinskyFM, GlaserB, MagnusonMA. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes, 47:307–315. 1998.
212.
MayJM, QuZC, LiX. Ascorbic acid blunts oxidant stress due to menadione in endothelial cells. Arch Biochem Biophys, 411:136–144. 2003.
213.
MayersRM, LeightonB, KilgourE. PDH kinase inhibitors: a novel therapy for type II diabetes?Biochem Soc Trans, 33:367–370. 2005.
214.
MehtaK, Van ThielDH, ShahN, MobarhanS. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev, 60:289–293. 2002.
215.
MensinkM, HesselinkMK, RussellAP, SchaartG, SelsJP, SchrauwenP. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond), 31:1302–1310. 2007.
MezzettiA, CipolloneF, CuccurulloF. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res, 47:475–488. 2000.
218.
MilneJC, LambertPD, SchenkS, CarneyDP, SmithJJ, GagneDJ, JinL, BossO, PerniRB, VuCB, BemisJE, XieR, DischJS, NgPY, NunesJJ, LynchAV, YangH, GalonekH, IsraelianK, ChoyW, IfflandA, LavuS, MedvedikO, SinclairDA, OlefskyJM, JirousekMR, ElliottPJ, WestphalCH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450:712–716. 2007.
219.
MitchellP. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature, 191:144–148. 1961.
220.
ModiK, SantaniDD, GoyalRK, BhattPA. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats. Biol Trace Elem Res, 109:25–34. 2006.
221.
MoorePC, UgasMA, HagmanDK, ParazzoliSD, PoitoutV. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes, 53:2610–2616. 2004.
222.
MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, LeharJ, PuigserverP, CarlssonE, RidderstraleM, LaurilaE, HoustisN, DalyMJ, PattersonN, MesirovJP, GolubTR, TamayoP, SpiegelmanB, LanderES, HirschhornJN, AltshulerD, GroopLC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet, 34:267–273. 2003.
223.
MoreiraPI, RoloAP, SenaC, SeicaR, OliveiraCR, SantosMS. Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med Chem, 2:299–308. 2006.
MuoioDM, NewgardCB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol, 9:193–205. 2008.
229.
MuradLB, GuimaraesMR, ViannaLM. Effects of decylubiquinone (coenzyme Q10 analog) supplementation on SHRSP. Biofactors, 30:13–18. 2007.
230.
MurphyMP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol, 15:326–330. 1997.
231.
MysoreTB, ShinkelTA, CollinsJ, SalvarisEJ, FisicaroN, Murray-SegalLJ, JohnsonLE, LeporeDA, WaltersSN, StokesR, ChandraAP, O'ConnellPJ, d'ApiceAJ, CowanPJ. Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes, 54:2109–2116. 2005.
232.
NassarT, KaderyB, LotanC, Da'asN, KleinmanY, Haj-YehiaA. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol, 436:111–118. 2002.
233.
NichollsDG. A history of UCP1. Biochem Soc Trans, 29:751–755. 2001.
234.
NichollsDG, Johnson-CadwellL, VesceS, JekabsonsM, YadavaN. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res, 85:3206–3212. 2007.
235.
NichollsDG, Johnson-CadwellL, VesceS, JekabsonsM, YadavaN, Johnson-CadwellLI, JekabsonsMB, WangA, PolsterBM, NichollsDG. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity: “mild uncoupling” does not decrease mitochondrial superoxide levels in cultured cerebellar granule neurons but decreases spare respiratory capacity and increases toxicity to glutamate and oxidative stress. J Neurosci Res, 101:1619–1631. 2007.
236.
NishikawaT, EdelsteinD, BrownleeM. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl, 77:S26–S30. 2000.
237.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404:787–790. 2000.
NisoliE, ClementiE, PaolucciC, CozziV, TonelloC, ScioratiC, BracaleR, ValerioA, FrancoliniM, MoncadaS, CarrubaMO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299:896–899. 2003.
240.
NovialsA, VidalJ, FrancoC, RiberaF, SenerA, MalaisseWJ, GomisR. Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochem Biophys Res Commun, 231:570–572. 1997.
241.
O'MalleyY, FinkBD, RossNC, PrisinzanoTE, SivitzWI. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem, 281:39766–39775. 2006.
242.
ObrosovaIG, DrelVR, KumagaiAK, SzaboC, PacherP, StevensMJ. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia, 49:2525–2533. 2006.
243.
ObrosovaIG, StevensMJ, LangHJ. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology, 62:172–180. 2001.
244.
OliveiraPJ, SeicaR, CoxitoPM, RoloAP, PalmeiraCM, SantosMS, MorenoAJ. Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats. FEBS Lett, 554:511–514. 2003.
245.
OprescuAI, BikopoulosG, NaassanA, AllisterEM, TangC, ParkE, UchinoH, LewisGF, FantusIG, Rozakis-AdcockM, WheelerMB, GiaccaA. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes, 56:2927–2937. 2007.
246.
PadmajaS, HuieRE. The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun, 195:539–544. 1993.
247.
PattiME, ButteAJ, CrunkhornS, CusiK, BerriaR, KashyapS, MiyazakiY, KohaneI, CostelloM, SacconeR, LandakerEJ, GoldfineAB, MunE, DeFronzoR, FinlaysonJ, KahnCR, MandarinoLJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A, 100:8466–8471. 2003.
248.
PearsonKJ, BaurJA, LewisKN, PeshkinL, PriceNL, LabinskyyN, SwindellWR, KamaraD, MinorRK, PerezE, JamiesonHA, ZhangY, DunnSR, SharmaK, PleshkoN, WoollettLA, CsiszarA, IkenoY, Le CouteurD, ElliottPJ, BeckerKG, NavasP, IngramDK, WolfNS, UngvariZ, SinclairDA, de CaboR. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab, 8:157–168. 2008.
249.
PerseghinG, GhoshS, GerowK, ShulmanGI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes, 46:1001–1009. 1997.
250.
PessinJE, RichardsonJM, SivitzWI. Regulation of the glucose transporter in animal models of diabetes. Adv Exp Med Biol, 293:249–262. 1991.
251.
PessinJE, SaltielAR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest, 106:165–169. 2000.
252.
PetersenKF, BefroyD, DufourS, DziuraJ, AriyanC, RothmanDL, DiPietroL, ClineGW, ShulmanGI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science, 300:1140–1142. 2003.
253.
PetersenKF, DufourS, BefroyD, GarciaR, ShulmanGI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. [see comment]N Engl J Med, 350:664–671. 2004.
254.
PetersenKF, DufourS, ShulmanGI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med, 2:e233. 2005.
255.
PetratF, PindiurS, KirschM, de GrootH. NAD(P)H, a primary target of 1O2 in mitochondria of intact cells. J Biol Chem, 278:3298–3307. 2003.
256.
PetriS, KiaeiM, DamianoM, HillerA, WilleE, ManfrediG, CalingasanNY, SzetoHH, BealMF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem, 98:1141–1148. 2006.
257.
PfeifferDR, GunterTE, EliseevR, BroekemeierKM, GunterKK. Release of Ca2+ from mitochondria via the saturable mechanisms and the permeability transition. IUBMB Life, 52:205–212. 2001.
PorterRK, BrMD. Mitochondrial proton conductance and H+/O ratio are independent of electron transport rate in isolated hepatocytes. Biochem J, 310:379–382. 1995.
260.
PospisilikJA, KnaufC, JozaN, BenitP, OrthoferM, CaniPD, EbersbergerI, NakashimaT, SaraoR, NeelyG, EsterbauerH, KozlovA, KahnCR, KroemerG, RustinP, BurcelinR, PenningerJM. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell, 131:476–491. 2007.
261.
RadiR, RodriguezM, CastroL, TelleriR. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys, 308:89–95. 1994.
262.
RadiR, TurrensJF, ChangLY, BushKM, CrapoJD, FreemanBA. Detection of catalase in rat heart mitochondria. J Biol Chem, 266:22028–22034. 1991.
RauscherFM, SandersRA, WatkinsJB3rd. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol, 15:41–46. 2001.
265.
RedmanLM, RavussinE. Endocrine alterations in response to calorie restriction in humans. Mol Cell Endocrinol, 299:129–136. 2008.
266.
ReznickRM, ShulmanGI. The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol, 574:33–39. 2006.
267.
RijzewijkLJ, van der MeerRW, SmitJW, DiamantM, BaxJJ, HammerS, RomijnJA, de RoosA, LambHJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol, 52:1793–1799. 2008.
268.
RitovVB, MenshikovaEV, HeJ, FerrellRE, GoodpasterBH, KelleyDE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes, 54:8–14. 2005.
269.
RocklKS, WitczakCA, GoodyearLJ. Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise. IUBMB Life, 60:145–153. 2008.
270.
RodenM. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci, 19:92–96. 2004.
271.
RodgersJT, LerinC, Gerhart-HinesZ, PuigserverP. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett, 582:46–53. 2008.
272.
RodgersJT, LerinC, HaasW, GygiSP, SpiegelmanBM, PuigserverP. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434:113–118. 2005.
273.
RodgersJT, PuigserverP. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A, 104:12861–12866. 2007.
274.
RoscaMG, MustataTG, KinterMT, OzdemirAM, KernTS, SzwedaLI, BrownleeM, MonnierVM, WeissMF. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol, 289:F420–F430. 2005.
275.
RosenP, WiernspergerNF. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress. Diabetes Metab Res Rev, 22:323–330. 2006.
276.
RudermanNB, SahaAK, KraegenEW. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology, 144:5166–5171. 2003.
277.
RussellAP, GastaldiG, Bobbioni-HarschE, ArboitP, GobeletC, DeriazO, GolayA, WitztumJL, GiacobinoJP. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?FEBS Lett, 551:104–106. 2003.
278.
SaitoM, Okamatsu-OguraY, MatsushitaM, WatanabeK, YoneshiroT, Nio-KobayashiJ, IwanagaT, MiyagawaM, KameyaT, NakadaK, KawaiY, TsujisakiM. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes, 58:1526–1531. 2009.
279.
SakuraiK, KatohM, SomenoK, FujimotoY. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan. Biol Pharm Bull, 24:876–882. 2001.
280.
SalviM, BattagliaV, BrunatiAM, La RoccaN, TibaldiE, PietrangeliP, MarcocciL, MondoviB, RossiCA, ToninelloA. Catalase takes part in rat liver mitochondria oxidative stress defense. J Biol Chem, 282:24407–24415. 2007.
281.
SaretzkiG, MurphyMP, von ZglinickiT. MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell, 2:141–143. 2003.
282.
SazanovLA. Respiratory complex I: mechanistic and structural insights provided by the crystal structure of the hydrophilic domain. Biochemistry, 46:2275–2288. 2007.
283.
SchaferM, SchaferC, EwaldN, PiperHM, NollT. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res, 92:1010–1015. 2003.
284.
SchefflerI. Mitochondrial electron transport and oxidative phosphorylation. Mitochondria. New York: Wiley-Liss, 1999; 141–245.
285.
SchillerPW, NguyenTM, BerezowskaI, DupuisS, WeltrowskaG, ChungNN, LemieuxC. Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem, 35:895–901. 2000.
SchrauwenP, HesselinkMK, BlaakEE, BorghoutsLB, SchaartG, SarisWH, KeizerHA. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes, 50:2870–2873. 2001.
288.
SchrauwenP, HesselinkMC. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes, 53:1412–1417. 2004.
289.
SeifertEL, BezaireV, EsteyC, HarperME. Essential role for uncoupling protein-3 in mitochondrial adaptation to fasting but not in fatty acid oxidation or fatty acid anion export. J Biol Chem, 283:25124–25131. 2008.
290.
SekineN, CirulliV, RegazziR, BrownLJ, GineE, Tamarit-RodriguezJ, GirottiM, MarieS, MacDonaldMJ, WollheimCBet al.Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells: potential role in nutrient sensing. J Biol Chem, 269:4895–4902. 1994.
291.
ShimabukuroM, ZhouYT, LeeY, UngerRH. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem, 273:3547–3550. 1998.
292.
SivitzWI, WaysonSM, BaylessML, SinkeyCA, HaynesWG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications, 21:149–157. 2007.
293.
SkovV, GlintborgD, KnudsenS, JensenT, KruseTA, TanQ, BrusgaardK, Beck-NielsenH, HojlundK. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes, 56:2349–2355. 2007.
294.
SkulachevVP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q Rev Biophys, 29:169–202. 1996.
295.
SkulachevVP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta, 1363:100–124. 1998.
296.
SmithAR, VisioliF, HagenTM. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J, 16:NIL_125–NIL_144. 2002.
297.
SohalRS, ForsterMJ. Coenzyme Q, oxidative stress and aging. Mitochondrion, 7,suppl:S103–S111. 2007.
298.
SparksLM, XieH, KozaRA, MynattR, HulverMW, BrayGA, SmithSR. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes, 54:1926–1933. 2005.
299.
St-PierreJ, BuckinghamJA, RoebuckSJ, BrMD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem, 4277:44784–44790. 2002.
300.
StuartJA, CadenasS, JekabsonsMB, RousselD, BrMD. Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim Biophys Acta, 1504:144–158. 2001.
301.
StumpCS, ShortKR, BigelowML, SchimkeJM, NairKS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A, 100:7996–8001. 2003.
302.
SuzukiS, HinokioY, OhtomoM, HiraiM, HiraiA, ChibaM, KasugaS, SatohY, AkaiH, ToyotaT. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia, 41:584–588. 1998.
303.
SzendroediJ, SchmidAI, ChmelikM, TothC, BrehmA, KrssakM, NowotnyP, WolztM, WaldhauslW, RodenM. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med, 4:e154. 2007.
304.
SzetoHH. Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann N Y Acad Sci, 1147:112–121. 2008.
TalbotDA, LambertAJ, BrMD. Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett, 556:111–115. 2004.
307.
TangC, HanP, OprescuAI, LeeSC, GyulkhandanyanAV, ChanGN, WheelerMB, GiaccaA. Evidence for a role of superoxide generation in glucose-induced beta-cell dysfunction in vivo. Diabetes, 56:2722–2731. 2007.
308.
ThiemermannC. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med, 31:S76–S84. 2003.
van der MeerRW, RijzewijkLJ, de JongHW, LambHJ, LubberinkM, RomijnJA, BaxJJ, de RoosA, KampO, PaulusWJ, HeineRJ, LammertsmaAA, SmitJW, DiamantM. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation, 119:2069–2077. 2009.
318.
van Marken LichtenbeltWD, VanhommerigJW, SmuldersNM, DrossaertsJM, KemerinkGJ, BouvyND, SchrauwenP, TeuleGJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med, 360:1500–1508. 2009.
319.
Vasquez-VivarJ, KalyanaramanB, KennedyMC. Mitochondrial aconitase is a source of hydroxyl radical: an electron spin resonance investigation. J Biol Chem, 284:19843–19855. 2000275: 14064–14069.
320.
VenkatakrishnanP, NakayasuES, AlmeidaIC, MillerRT. Absence of nitric oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem, 284:19843–19855. 2009.
321.
VercesiAE, KowaltowskiAJ, GrijalbaMT, MeinickeAR, CastilhoRF. The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep, 17:43–52. 1997.
322.
VesterJW, StadieWC. Studies of oxidative phosphorylation by hepatic mitochondria from the diabetic cat. J Biol Chem, 227:669–676. 1957.
323.
VirtanenKA, LidellME, OravaJ, HeglindM, WestergrenR, NiemiT, TaittonenM, LaineJ, SavistoNJ, EnerbackS, NuutilaP. Functional brown adipose tissue in healthy adults. N Engl J Med, 360:1518–1525. 2009.
324.
VotyakovaTV, ReynoldsIJ. DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem, 79:266–277. 2001.
325.
WalderK, Kerr-BaylesL, CivitareseA, JowettJ, CurranJ, ElliottK, TrevaskisJ, BisharaN, ZimmetP, MandarinoL, RavussinE, BlangeroJ, KissebahA, CollierGR. The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia, 48:459–468. 2005.
326.
WangMY, ShimabukuroM, LeeY, TrinhKY, ChenJL, NewgardCB, UngerRH. Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves beta-cell function. Diabetes, 48:1020–1025. 1999.
327.
WiederkehrA, WollheimCB. Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic beta-cell. Cell Calcium, 44:64–76. 2008.
328.
WilliamsonJR, ChangK, FrangosM, HasanKS, IdoY, KawamuraT, NyengaardJR, van den EndenM, KiloC, TiltonRG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes, 42:801–813. 1993.
329.
WinderWW, HolmesBF, RubinkDS, JensenEB, ChenM, HolloszyJO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol, 88:2219–2226. 2000.
330.
WolfrumC, AsilmazE, LucaE, FriedmanJM, StoffelM. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature, 432:1027–1032. 2004.
331.
WoodJG, RoginaB, LavuS, HowitzK, HelfandSL, TatarM, SinclairD. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430:686–689. 2004.
332.
WredenbergA, FreyerC, SandstromME, KatzA, WibomR, WesterbladH, LarssonNG. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun, 350:202–207. 2006.
333.
WredenbergA, WibomR, WilhelmssonH, GraffC, WienerHH, BurdenSJ, OldforsA, WesterbladH, LarssonNG. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A, 99:15066–15071. 2002.
334.
WuZ, PuigserverP, AnderssonU, ZhangC, AdelmantG, MoothaV, TroyA, CintiS, LowellB, ScarpullaRC, SpiegelmanBM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98:115–124. 1999.
335.
YamagishiSI, EdelsteinD, DuXL, KanedaY, GuzmanM, BrownleeM. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem, 276:25096–25100. 2001.
YangX, SmithU. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?Diabetologia, 50:1127–1139. 2007.
338.
YeG, MetreveliNS, DonthiRV, XiaS, XuM, CarlsonEC, EpsteinPN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes, 53:1336–1343. 2004.
339.
YiX, MaedaN. alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes, 55:2238–2244. 2006.
340.
YokotaT, MaRC, ParkJY, IsshikiK, SotiropoulosKB, RauniyarRK, BornfeldtKE, KingGL. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes, 52:838–845. 2003.
341.
YorekMA. The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res, 37:471–480. 2003.
342.
YorekMA, CoppeyLJ, GellettJS, DavidsonEP, BingX, LundDD, DillonJS. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab, 283:E1067–E1075. 2002.
343.
YorekMA, CoppeyLJ, GellettJS, DavidsonEP, LundDD. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction. Exp Diabesity Res, 5:123–135. 2004.
344.
YuXX, BargerJL, BoyerBB, BrandMD, PanG, AdamsSH. Impact of endotoxin on UCP homolog mRNA abundance, thermoregulation, and mitochondrial proton leak kinetics. Am J Physiol Endocrinol Metab, 279:E433–E446. 2000.
345.
YusufS, DagenaisG, PogueJ, BoschJ, SleightP. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med, 342:154–160. 2000.
346.
ZhangCY, BaffyG, PerretP, KraussS, PeroniO, GrujicD, HagenT, Vidal-PuigAJ, BossO, KimYB, ZhengXX, WheelerMB, ShulmanGI, ChanCB, LowellBB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes [comment]Cell, 105:745–755. 2001.
347.
ZhaoGM, QianX, SchillerPW, SzetoHH. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at μ, d, and κ opioid receptors. J Pharmacol Exp Ther, 307:947–954. 2003.
348.
ZhaoK, LuoG, ZhaoGM, SchillerPW, SzetoHH. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther, 304:425–432. 2003.
ZickY. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE, 2005:pe4. 2005.
351.
ZieglerD, AmetovA, BarinovA, DyckPJ, GurievaI, LowPA, MunzelU, YakhnoN, RazI, NovosadovaM, MausJ, SamigullinR. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care, 29:2365–2370. 2006.
352.
ZieglerD, HanefeldM, RuhnauKJ, MeissnerHP, LobischM, SchutteK, GriesFA. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid: a 3-week multicentre randomized controlled trial (ALADIN Study)Diabetologia, 38:1425–1433. 1995.
353.
ZouMH, KirkpatrickSS, DavisBJ, NelsonJS, WilesWGt, SchlattnerU, NeumannD, BrownleeM, FreemanMB, GoldmanMH. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: role of mitochondrial reactive nitrogen species. J Biol Chem, 279:43940–43951. 2004.
